SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001628280-18-005107
Filing Date
2018-04-26
Accepted
2018-04-26 16:02:55
Documents
5
Effectiveness Date
2018-04-26

Document Format Files

Seq Description Document Type Size
1 DEFA14A adms123118proxyadditionalm.htm DEFA14A 32505
2 notice20181.jpg GRAPHIC 165220
3 notice20182.jpg GRAPHIC 267533
4 notice20183.jpg GRAPHIC 82277
5 notice20184.jpg GRAPHIC 46338
  Complete submission text file 0001628280-18-005107.txt   806427
Mailing Address 1900 POWELL ST., SUITE 750 EMERYVILLE CA 94608
Business Address 1900 POWELL ST., SUITE 750 EMERYVILLE CA 94608 510-450-3554
Adamas Pharmaceuticals Inc (Filer) CIK: 0001328143 (see all company filings)

IRS No.: 421560076 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-36399 | Film No.: 18778471
SIC: 2834 Pharmaceutical Preparations